Testosterone Gel 5% is a transdermal androgen research gel supplied in a 60 pump format. Manufactured for consistent potency, stable transdermal delivery, and controlled research applications.
AndroGel is a pharmaceutical transdermal testosterone gel formulation delivering 1% testosterone in single use 2.5g packets, a topical delivery route that distinguishes it fundamentally from every injectable testosterone ester in CSD’s range. This 30 packet supply provides a one month research quantity at standard once daily application, consistent with the dosing frequency most commonly referenced in clinical testosterone replacement therapy literature.
Transdermal testosterone delivery operates through an entirely different pharmacokinetic pathway from injectable esters. Rather than relying on an ester chain to control release rate as with Enanthate, Cypionate, or Decanoate, AndroGel delivers unesterified testosterone directly through percutaneous absorption across the skin barrier into systemic circulation. This produces a relatively stable daily testosterone concentration profile without the peak and trough pattern characteristic of injectable esters. Daily application maintains more consistent blood levels day to day, though absorption can vary based on application site, skin condition, and individual absorption rate, making transdermal delivery a frequently studied research subject in comparative bioavailability and pharmacokinetic variability literature.
AndroGel’s research relevance extends to its well documented secondary transfer risk, a pharmacological consideration unique to topical testosterone formulations. Testosterone gel remains bioavailable on skin surface for a period following application, creating potential for transfer to other individuals through skin contact; a risk profile studied extensively in clinical literature and entirely absent from injectable, oral, or peptide delivery routes. This transfer risk consideration, alongside its non invasive application method and the comparative pharmacokinetics of transdermal versus injectable testosterone delivery, makes AndroGel a distinct research subject within CSD’s testosterone range; valuable for studies examining route of administration effects on testosterone bioavailability, absorption variability, and steady state concentration maintenance.
Every batch of CSD’s AndroGel is third party verified for concentration accuracy and purity, with documentation available on request. Canada Steroid Depot has supplied Canadian customers with consistently verified, accurately dosed compounds for years, and our TRT range now spans transdermal, injectable, and oral testosterone delivery formats for complete comparative route of administration research. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at room temperature away from direct light and heat. Wash hands thoroughly after application. Intended for research purposes only.
Commonly researched alongside injectable testosterone esters in comparative transdermal versus parenteral bioavailability studies. Browse CSD’s full TRT and injectable testosterone range for complete sourcing.
$290.00
